Myelitis: Clinical Trials

2 trials for Myelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 2

Follow Myelitis: new trials by email Literature Review of Myelitis trials Research Report on Myelitis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection
"Raltegravir" and "Zidovudine" - HTLV-I Infections, Tropical Spastic Paraparesis
Early Phase 1CompletedUniversidad Peruana Cayetano Heredia102017-07-012019-05-22
Raltegravir for HAM/TSP
Raltegravir - HTLV-I Infection
Early Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)192013-09-052023-03-30

Narrower conditions

HTLV-I Infections (2)  ·  Paraparesis, Tropical Spastic (2)

Broader conditions

Central Nervous System Diseases (2)  ·  Central Nervous System Infections (2)  ·  Deltaretrovirus Infections (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Infections (2)  ·  Nervous System Diseases (2)  ·  Neuroinflammatory Diseases (2)  ·  RNA Virus Infections (2)  ·  Retroviridae Infections (2)  ·  Spinal Cord Diseases (2)  ·  Virus Diseases (2)

Interventions

Raltegravir Potassium (2)  ·  Zidovudine (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Universidad Peruana Cayetano Heredia (1)

Countries

Peru (1)  ·  United States (1)

Top investigators

Eduardo Gotuzzo, MD (1)  ·  Steven Jacobson, Ph.D. (1)

Results publications

PMID 12522449, PMID 15472843, PMID 17376384, PMID 19578703, PMID 20573027, PMID 21343468, PMID 21965433, PMID 22227566, PMID 34562313, PMID 7760890, PMID 9180608